We’ve Already Paid for the Coronavirus Vaccine

Photo by Getty Images

Pfizer and Moderna, two powerhouse pharmaceutical companies with equity positions in the billions, have been in the news as of late for their COVID-19 vaccine breakthroughs.

The Pfizer vaccine shows positive results in phase III trials with an over 90% rate of preventing the disease, and Moderna’s vaccine is an even better 94.5% rate of preventing the disease.

--

--

--

Writer observing the quirks of modern life in late-stage capitalism, and other uplifting subjects. These Troubled Days Available online and in retailers!

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

What is digital transformation really?

Fast Fashion: Who Pays For It?

The Challenges with Innovation for Legacy Organizations

Big Data: The Savior of Retail?

FAIR PLAY — A Response to the ACCC Determination to Reauthorise APRA

American Airlines On Why We’re Last In Customer Satisfaction: TBH, We Just Don’t Care…

American Airlines On Why We’re Last In Customer Satisfaction: TBH, We Just Don't Care...

Described Inventory Forecasting Tools and Methods for Optimizing Inventory Process

A Conversation with Affirm’s CEO Max Levchin

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
James Tarr

James Tarr

Writer observing the quirks of modern life in late-stage capitalism, and other uplifting subjects. These Troubled Days Available online and in retailers!

More from Medium

Hanging Up Your Sword — Retirement in the NFL

Climate Change and Pollution

Spring Climate Outlook in New England: Leaning Warmer Than Normal

Eugeniac Drivers